Literature DB >> 23872692

The phenotype characteristics of type 13 long QT syndrome with mutation in KCNJ5 (Kir3.4-G387R).

Fan Wang1, Jinqiu Liu, Li Hong, Bo Liang, Claus Graff, Yanzong Yang, Michael Christiansen, Søren-Peter Olesen, Li Zhang, Jørgen K Kanters.   

Abstract

BACKGROUND: Long QT syndrome type 13 (LQT13) is caused by loss-of-function mutation in the KCNJ5-encoded cardiac G-protein-coupled inward rectifier potassium channel subtype 4 protein. The electrocardiographic (ECG) features of LQT13 are not described yet.
OBJECTIVE: To describe for the first time in detail the phenotype-genotype relationship of the ECG and clinical features in patients with LQT13.
METHODS: The 12-lead ECGs, 24-hour Holter recordings, and clinical information from KCNJ5-G387R mutation carriers of a fourth-generation Han Chinese family with LQT13 and a group of healthy Chinese individuals were analyzed.
RESULTS: Compared with the analysis of the healthy group (n = 8), age- and sex-matched pair analysis revealed that the mutation carriers (n = 8) had ventricular repolarization abnormality results in the prolongation of corrected QT and QTpeak intervals (P < .01); greater combined measure of repolarization morphology (T-wave morphology combination score) based on asymmetry, flatness, and notch (P < .01); and reduced low frequency/high frequency ratio of heart rate variability (P < .01) as a reflection of cardiac autonomic imbalance. Mean heart rate, time domain parameters of heart rate variability, time interval from T-wave peak to T-wave end, and T-wave amplitude were similar.
CONCLUSIONS: This study demonstrates for the first time the ECG features of patients with LQT13. Our data suggest that QTpeak intervals and T-wave morphology combination score may be the better parameters than the corrected QT interval to predict the phenotype-genotype relationship in patients with LQT13.
© 2013 Heart Rhythm Society. All rights reserved.

Entities:  

Keywords:  AAI; AF; APD; AVB; ECG; G-protein coupled inward rectifier potassium channel subtype 4 protein; GIRK4; HRV; Heart rate variability; I(K,ACh)(I(GIRK)); Kir3.4 (GIRK4); LF/HF; LQT13; LQTS; MCS; Morphology combination score; QT; QTc; QTcF; RMP; T-wave morphology; T-wave morphology combination score; TpTe; VVI; acetylcholine/adenosine-induced potassium current; action potential duration; atrial fibrillation; atrioventricular block; atrium paced, atrium sensed, and pacemaker inhibited in response to sensed beat; corrected QT interval; corrected QT interval for heart rate using the formula QTcF = QT/RR(1/3); electrocardiogram/electrocardiographic; heart rate variability; long QT syndrome; long QT syndrome type 13; low frequency/high frequency ratio; resting membrane potential; time interval from T-wave peak to T-wave end; ventricle paced, ventricle sensed, and pacemaker inhibited in response to sensed beat

Mesh:

Substances:

Year:  2013        PMID: 23872692     DOI: 10.1016/j.hrthm.2013.07.022

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  9 in total

1.  RGS6, but not RGS4, is the dominant regulator of G protein signaling (RGS) modulator of the parasympathetic regulation of mouse heart rate.

Authors:  Nicole Wydeven; Ekaterina Posokhova; Zhilian Xia; Kirill A Martemyanov; Kevin Wickman
Journal:  J Biol Chem       Date:  2013-12-06       Impact factor: 5.157

Review 2.  The Genetics and Epigenetics of Ventricular Arrhythmias in Patients Without Structural Heart Disease.

Authors:  Mengru Wang; Xin Tu
Journal:  Front Cardiovasc Med       Date:  2022-06-15

Review 3.  Genetic and non-genetic risk factors associated with atrial fibrillation.

Authors:  Lindsay J Young; Steve Antwi-Boasiako; Joel Ferrall; Loren E Wold; Peter J Mohler; Mona El Refaey
Journal:  Life Sci       Date:  2022-04-03       Impact factor: 6.780

Review 4.  New insights into the therapeutic potential of Girk channels.

Authors:  Rafael Luján; Ezequiel Marron Fernandez de Velasco; Carolina Aguado; Kevin Wickman
Journal:  Trends Neurosci       Date:  2013-11-21       Impact factor: 13.837

5.  Characterization of VU0468554, a New Selective Inhibitor of Cardiac G Protein-Gated Inwardly Rectifying K+ Channels.

Authors:  Allison Anderson; Baovi N Vo; Ezequiel Marron Fernandez de Velasco; Corey R Hopkins; C David Weaver; Kevin Wickman
Journal:  Mol Pharmacol       Date:  2021-09-09       Impact factor: 4.436

6.  Expression and relevance of the G protein-gated K+ channel in the mouse ventricle.

Authors:  Allison Anderson; Kanchan Kulkarni; Ezequiel Marron Fernandez de Velasco; Nicholas Carlblom; Zhilian Xia; Atsushi Nakano; Kirill A Martemyanov; Elena G Tolkacheva; Kevin Wickman
Journal:  Sci Rep       Date:  2018-01-19       Impact factor: 4.379

Review 7.  Sudden cardiac death: focus on the genetics of channelopathies and cardiomyopathies.

Authors:  Simona Magi; Vincenzo Lariccia; Marta Maiolino; Salvatore Amoroso; Santo Gratteri
Journal:  J Biomed Sci       Date:  2017-08-15       Impact factor: 8.410

Review 8.  Ion Channel Disorders and Sudden Cardiac Death.

Authors:  Anna Garcia-Elias; Begoña Benito
Journal:  Int J Mol Sci       Date:  2018-02-28       Impact factor: 5.923

Review 9.  Genetic Complexity of Sinoatrial Node Dysfunction.

Authors:  Michael J Wallace; Mona El Refaey; Pietro Mesirca; Thomas J Hund; Matteo E Mangoni; Peter J Mohler
Journal:  Front Genet       Date:  2021-04-01       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.